Latest Financial Results

Q1 2018

Quarterly Results

Ended Jan 31, 2018

Stock Information

Symbol

ITUS

Price

Change

Volume

52 week Low/High

Day Low/High

Company Overview

ITUS Corporation is developing a platform called Cchek™, a series of inexpensive non-invasive blood tests for the early detection of cancer.

Logo Itus

Latest News & Events

ITUS Corporation to Present at the 3rd Annual Disruptive Growth & Healthcare Conference Hosted by RHK Capital and ReedSmith

Read More...

ITUS Presentation to Special Meeting of Stockholders

Read More...

ITUS and Serametrix Announce Results of a Blinded Prostate Cancer Study

Read More...

Cancer Fact: Approximately 40 million mammograms are conducted annually.